Reported Q: Q1 2025 Rev YoY: +24.7% EPS YoY: +547.1% Move: +0.63%
ProDex Inc
PDEX
$39.70 0.63%
Exchange NASDAQ Sector Healthcare Industry Medical Instruments Supplies
Q1 2025
Published: Oct 31, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for PDEX

Reported

Report Date

Oct 31, 2024

Quarter Q1 2025

Revenue

14.89M

YoY: +24.7%

EPS

0.75

YoY: +547.1%

Market Move

+0.63%

Previous quarter: Q4 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $14.89M up 24.7% year-over-year
  • EPS of $0.75 increased by 547.1% from previous year
  • Gross margin of 34.6%
  • Net income of 2.47M
  • "No transcript data available for QQ1 2025." -
PDEX
Company PDEX

Executive Summary

ProDex Inc reported a solid QQ1 2025 (quarter ended 2024-09-30) with meaningful top-line growth and margin expansion, signaling operating leverage at a small-cap medical devices player. Revenue reached $14.892 million, up 24.7% year over year, while gross profit rose to $5.15 million for a gross margin of approximately 34.6%. EBITDA stood at $3.773 million and operating income was $3.013 million, yielding an operating margin around 20.2%. Net income of $2.467 million contributed to an EPS of $0.76, reflecting a substantial YoY uplift (EPS up ~547%) and QoQ improvement (~62%).

Key Performance Indicators

Revenue
Increasing
14.89M
QoQ: -0.89% | YoY: 24.74%
Gross Profit
Increasing
5.15M
34.58% margin
QoQ: 22.79% | YoY: 40.79%
Operating Income
Increasing
3.01M
QoQ: 28.16% | YoY: 64.38%
Net Income
Increasing
2.47M
QoQ: 55.39% | YoY: 500.98%
EPS
Increasing
0.76
QoQ: 61.70% | YoY: 547.06%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q3 2025 17.41 0.98 +21.8% View
Q2 2025 16.79 0.61 +33.4% View
Q1 2025 14.89 0.75 +24.7% View
Q4 2024 15.03 0.46 +41.2% View
Q3 2024 14.29 0.19 +9.3% View